[3]
Rosenkrantz AB, Verma S, Choyke P, et al. Prostate magnetic reso- nance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol 2016;196:1613–8.
[4]
Moldovan PC, Van den Broeck T, Sylvester R, et al. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urolo- gy Prostate Cancer Guidelines Panel. Eur Urol 2017;72:250–66.[5]
Tosoian JJ, Druskin SC, Andreas D, et al. Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice. Prostate Cancer Prostatic Dis 2017;20:228–33.
Stacy Loeb
*
Department of Urology and Population Health,
New York University and Manhattan Veterans Affairs,
New York, NY, USA
*
[2_TD$DIFF]
227
[3_TD$DIFF]
E30
[4_TD$DIFF]
St
[5_TD$DIFF]
(#612), New York, NY
[6_TD$DIFF]
100016, USA.
E-mail address:
stacyloeb@gmail.com . http://dx.doi.org/10.1016/j.eururo.2017.06.016#
2017 European Association of Urology.
Published by Elsevier B.V. All rights reserved.
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 6 5 0 – 6 5 5
655




